ArticleJournal of experimental & clinical cancer research : CR2025

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer.

Juliana Calheiros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.